Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

National Institute of Biomedical Innovation and Biken synthesize lipid A adjuvant

Sep. 21, 2018

UCB-9608 is a potent and orally available immunosuppressive agent with promising in vivo activity

Sep. 19, 2018

How to spot a good TB vaccine

Sep. 18, 2018

Researchers present preclinical data for PDE4B inhibitor VFP-B-3

Sep. 13, 2018

DSMB recommends continuation of EPITOPE study of Viaskin Peanut in toddlers

Sep. 12, 2018

PI3Kdelta in autoimmunity

Sep. 7, 2018

Argenx initiates phase III trial of efgartigimod in generalized myasthenia gravis

Sep. 6, 2018

National Institute of Pharmaceutical R&D divulges BTK ihibitors

Sep. 5, 2018

New phase I trial evaluates Inovio's GLS-6150 to prevent hepatitis C

Sep. 5, 2018

Synthetic oligosaccharide conjugate vaccine for shigellosis evaluated in phase I trial

Sep. 4, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...